Skip to content
Science
Our Science
Autoimmunity
P140
Type M & Diagnostic
Type 1 Diabetes
Kapiglucagon
Anti-infectives
BioAMB
BioCIN
Pipeline
Company
Mission
About Us
Our Team
ImmuPharma Biotech
Investors
Investors
AIM Rule 26 Information
Regulatory News
Corporate Governance
Board of Directors
Annual Reports
Advisers
Email Alert
Updates
Announcements
Interviews
In the Media
Contact
Annual Reports
Download our Annual Reports
Annual Report
2025
Annual Report
2024
Annual Report
2023
Annual Report
2022
Annual Report
2021
Annual Report
2020
Annual Report
2019
Annual Report
2018
Annual Report
2017
Annual Report
2016
Annual Report
2015